Does commission on cancer (CoC) accreditation mitigate the effect of care fragmentation on clinical outcome in localized rectal cancer?
Am J Surg
; 230: 63-67, 2024 Apr.
Article
in En
| MEDLINE
| ID: mdl-38148258
ABSTRACT
BACKGROUND:
Studies of fragmented care (FC) in rectal cancer have not adjusted for indicators of hospital quality and may misrepresent the effects of FC.METHODS:
We queried the National Cancer Database to identify patients undergoing care for clinical stage II and III rectal adenocarcinoma between 2006 and 2019. Those undergoing FC were sub-categorized based on whether (FC CoC) or not (FC non-CoC) they received systemic therapy at CoC accredited facilities.RESULTS:
44,339 patients met inclusion criteria; 23,921 (54 â%) underwent FC, 16,929 (71 â%) FC non-CoC. Differences in utilization of neoadjuvant therapy (92.3 â% vs 89.7 â% vs 89.5 â%, p â< â0.01) and 5-year overall survival (76.1 vs 75.5 vs 74.1 %, p â< â0.01) between treatment cohorts were marginal.CONCLUSION:
In patients undergoing multimodality therapy for rectal cancer, care fragmentation is not associated with long-term clinical outcome. Decisions regarding where these patients go for systemic therapy may be safely made on the basis of ease of access.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Rectal Neoplasms
Limits:
Humans
Language:
En
Journal:
Am J Surg
Year:
2024
Type:
Article
Affiliation country:
United States